Removal of ibuprofen and its transformation products: Experimental and simulation studies

Science of the Total Environment

Volumn 433, Issue , 2012, Pages 296-301

  Collado, N ^a   Buttiglieri, G ^a   Ferrando Climent, L ^a   Rodriguez Mozaz, S ^a   Barcelo D ^a,b   Comas, J ^a   Rodriguez Roda, I ^a  

^a UNIVERSITY OF GIRONA   (Spain)

^b INSTITUTE OF ENVIRONMENTAL ASSESSMENT AND WATER RESEARCH   (Spain)

Author keywords

Biodegradation; Ibuprofen; Kinetics; Transformation products

Indexed keywords

AQUATIC ENVIRONMENTS; BATCH TESTS; BIOLOGICAL DEGRADATION; CLASSIFICATION SCHEME; DEGRADATION DATA; ENVIRONMENTAL COMPARTMENT; EXPERIMENTAL CONDITIONS; EXPERIMENTAL DATA; FORMATION KINETICS; HUMAN HEALTH; IBUPROFEN; LIQUID PHASE; PARENT COMPOUNDS; PHARMACEUTICAL COMPOUNDS; PHARMACEUTICALLY ACTIVE COMPOUNDS; PSEUDO-FIRST ORDER KINETICS; REMOVAL EFFICIENCIES; SIMULATION STUDIES; SLUDGE CHARACTERISTICS; SUSPENDED SOLIDS; TARGET COMPOUND; TRANSFORMATION PRODUCTS;

DEGRADATION; ENZYME KINETICS; ISOMERS; KINETICS; METADATA; MICROBIOLOGY;

BIODEGRADATION;

1 HYDROXYLIBUPROFEN; CARBOXYLIBUPROFEN; IBUPROFEN; UNCLASSIFIED DRUG;

BIODEGRADATION; BIOMASS; CONCENTRATION (COMPOSITION); DRUG; EXPERIMENTAL STUDY; REACTION KINETICS; SIMULATION;

ACTIVATED SLUDGE; ARTICLE; BIODEGRADATION; BIOMASS; CONTROLLED STUDY; DEGRADATION KINETICS; DRUG STRUCTURE; DRUG TRANSFORMATION; EXPERIMENTAL STUDY; LIQUID; PRIORITY JOURNAL; SIMULATION; WASTE COMPONENT REMOVAL; WATER TREATMENT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIODEGRADATION, ENVIRONMENTAL; IBUPROFEN; KINETICS; REPRODUCIBILITY OF RESULTS; SEWAGE; WATER POLLUTANTS, CHEMICAL;

EID: 84863734345     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2012.06.060     Document Type: Article

References (37)

1. Abegglen C., Joss A., McArdell C.S., Fink G., Schlüsener M.P., Ternes T.A., et al. The fate of selected micropollutants in a single-house MBR. Water Res 2009, 43:2036-2046.
2. Barceló D., Petrovic M. Pharmaceuticals and personal care products (PPCPs) in the environment. Anal Bioanal Chem 2007, 387:1141-1142.
3. Bartelt-Hunt S.L., Snow D.D., Damon T., Shockley J., Hoagland K. The occurrence of illicit and therapeutic pharmaceuticals in wastewater effluent and surface waters in Nebraska. Environ Pollut 2009, 157:786e-791e.
4. Benedetti L., De Baets B., Nopens I., Vanrolleghem P.A. Multi-criteria analysis of wastewater treatment plant design and control scenarios under uncertainty. Environ Model Softw 2010, 25(5):616-621.
5. Buser H.R., Poiger T., Müller M.D. Occurrence and environmental behaviour of chiral pharmaceutical drug ibuprofen in surface waters and in wastewater. Environ Sci Technol 1999, 33:2529-2535.
6. Buttiglieri G., Knepper T.P. Removal of emerging contaminants in wastewater treatment: conventional activated sludge treatment. Volume 5: emerging contaminants from industrial and municipal wastewaters 2008, 5 S2:1-35. Springer. D. Barceló, M. Petrovic (Eds.).
7. Carballa M., Omil F., Lema J.M. Comparison of predicted and measured concentrations of selected pharmaceuticals, fragrances and hormones in Spanish sewage. Chemosphere 2008, 72(8):1118-1123.
8. Castiglioni S., Bagnati R., Fanelli R., Pomati F., Calamari D., Zuccato E. Removal of pharmaceuticals in sewage treatment plants in Italy. Environ Sci Technol 2006, 40:357e-363.
9. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agent of subtable change?. Environ Health Perspect 1999, 107:907-938.
10. Dolar D, Gros M, Rodriguez-Mozaz S, Moreno J, Comas J, Rodriguez-Roda I, Barceló D. Removal mechanism of emerging contaminants from municipal wastewater with MBR-RO system. in preparation.
11. Gernaey K.V., van Loosdrecht M.C.M., Henze M., Lind M., Jorgensen S.B. Activated sludge wastewater treatment plant modelling and simulation: state of the art. Environ Model Softw 2004, 19(9):763-783.
12. Han S., Choi K., Kim J., Ji K., Kim S., Ahn B., et al. Endocrine disruption and consequences of chronic exposure to ibuprofen in Japanese medaka (Oryzias latipes) and freshwater cladocerans Daphnia magna and Moina macrocopa. Aquat Toxicol 2010, 98(3):256-264.
13. Hayashi Y., Heckmann L.H., Callaghan A., Sibly R.M. Reproduction recovery of the crustacean Daphnia magna after chronic exposure to ibuprofen. Ecotoxicology 2008, 17(4):246-251.
14. Heberer T. Tracking persistent pharmaceutical residues from municipal sewage to drinking water. J Hydrol 2002, 266:175-189.
15. Joss A., Zabczynski S., Göbel A., Hoffmann B., Löffler D., McArdell C.S., et al. Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme. Water Res 2006, 40(8):1686-1696.
16. Joss A., Siegrist H., Ternes T.A. Are we about to upgrade wastewater treatment for removing organic micropollutants. Water Sci Technol 2008, 57(2):251-255.
17. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ Sci Technol 2002, 36:1202-1211.
18. Kosjek T., Heath E., Kompare B. Removal of pharmaceutical residues in a pilot wastewater treatment plant. Anal Bioanal Chem 2007, 387:1379-1387.
19. Onesios K.M., Yu J.T., Bouwer E.J. Biodegradation and removal of pharmaceutical and personal care products in treatment systems: a review. Biodegradation 2009, 20:441-466.
20. Plósz B.G., Leknes H., Thomas K.V. Impacts of competitive inhibition, parent compound formation and partitioning behaviour on antibiotic micro-pollutants removal in activated sludge: measurements and modelling. Environ Sci Technol 2010, 44(2):734-742.
21. Plósz BGy, De Clercq J., Nopens I., Benedetti L., Vanrolleghem P.A. Shall we upgrade one-dimensional secondary settler models used in WWTP simulators? - an assessment of model structure uncertainty and its propagation. Water Sci Technol 2011, 63(8):1726-1738.
22. Quintana B., Weiss S., Reemtsma T. Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. Water Res 2005, 39:2654-2664.
23. Ragugnetti M., Adams M.L., Guimaraes A.T.B., Sponchiado G., de Vasconcelos E.C., de Oliveira C.M.R. Ibuprofen genotoxicity in aquatic environment: an experimental model using Oreochromis niloticus. Water Air Soil Pollut 2011, 218(1-4):361-364.
24. Santos J.L., Aparicio I., Callejon M., Alonso E. Occurrence of pharmaceutically active compounds during 1-year period in wastewaters from four wastewater treatment plants in Seville (Spain). J Hazard Mater 2009, 164(2-3):1509-1516.
25. Santos L.H.M.L.M., Araùjo A.N., Fachini A., Pena A., Delerue-Matos C. Montenegro MCBSM ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment: review. J Hazard Mater 2010, 175:45-95.
26. Schnell S., Bols N.C., Barata C., Porte C. Single and combined toxicity of pharmaceuticals and personal care products (PPCPs) on the rainbow trout liver cell line RTL-W1. Aquat Toxicol 2009, 93:244e-252e.
27. Schwarzenbach R.P., Gschwend P.M., Imboden D.M. Environmental organic chemistry 2003, Wiley-Interscience, Hoboken, NJ.
28. Smook T.M., Zho H., Zytner R.G. Removal of ibuprofen from wastewater: comparing biodegradation in conventional, membrane bioreactor, and biological nutrient removal treatment systems. Water Sci Technol 2008, 57(1):1-8.
29. Stumpf M., Ternes T.A., Wilken R.D., Rodrigues S.V., Baumann W. Polar drug residue in sewage and natural waters in the state of Rio de Janeiro, Brazil. Sci Total Environ 1999, 225:135-141.
30. Tambosi J.L., de Sena R.F., Favier M., Gebhardt W., José H.J., Schröder H.F., et al. Removal of pharmaceutical compounds in membrane bioreactors (MBR) applying submerged membranes. Desalination 2010, 261(1-2):148-156.
31. Ternes T.A., Joss A. Human pharmaceuticals, hormones and fragrances - the challenge of micropollutants in urban water management 2006, IWA Publishing, London, UK.
32. Tixier C., Singer H.P., Oellers S., Müller S.R. Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ Sci Technol 2003, 37(6):1061-1068.
33. Tran N.H., Urase T., Kusakabe O. The characteristics of enriched nitrifier culture in the degradation of selected pharmaceutically active compounds. J Hazard Mater 2009, 171(1-3):1051-1057.
34. Urase T., Kikuta T. Separate estimation of adsorption and degradation of pharmaceutical substances and estrogens in the activated sludge process. Water Res 2005, 39(7):1289-1300.
35. Van Loosdrecht M.C.M., Heijnen J.J. Modelling of activated sludge processes with structured biomass. Water Sci Technol 2002, 45(6):13-23.
36. Verlicchi P., Al Aukidy M., Zambello E. Occurrence of pharmaceutical compounds in raw wastewater: Removal, mass load and environmental risk after a secondary treatment-a review. Sci Total Environ 2012, (http://dx.doi.org/10.1016/j.scitotenv.2012.04.028).
37. Zwiener C., Seeger G., Glauner T., Frimmel F.H. Metabolites from the biodegradation of pharmaceutical residues of ibuprofen in biofilm reactors and batch experiments. Anal Bioanal Chem 2002, 372:569-575.